Skip to content
← Back to this collection

PUBLICATIONS · 34871104

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Feb 1
First author
Furman WL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Furman WL
      type
      Author
    2. name
      McCarville B
      type
      Author
    3. name
      Shulkin BL
      type
      Author
    4. name
      Davidoff A
      type
      Author
    5. name
      Krasin M
      type
      Author
    6. name
      Hsu CW
      type
      Author
    7. name
      Pan H
      type
      Author
    8. name
      Wu J
      type
      Author
    9. name
      Brennan R
      type
      Author
    10. name
      Bishop MW
      type
      Author
    11. name
      Helmig S
      type
      Author
    12. name
      Stewart E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Furman WL
      type
      Author
    2. name
      McCarville B
      type
      Author
    3. name
      Shulkin BL
      type
      Author
    4. name
      Davidoff A
      type
      Author
    5. name
      Krasin M
      type
      Author
    6. name
      Hsu CW
      type
      Author
    7. name
      Pan H
      type
      Author
    8. name
      Wu J
      type
      Author
    9. name
      Brennan R
      type
      Author
    10. name
      Bishop MW
      type
      Author
    11. name
      Helmig S
      type
      Author
    12. name
      Stewart E
      type
      Author
    bibliography ids
    1. nci-bib-82f56d7f6337f3ea0cffa7f8
    book metadata
    content sha256
    01873c88922075833d26c3072f4890f84651e629d26e48e52b13ec1897f7088d
    document type
    citation
    dois
    1. 10.1200/JCO.21.01375
    electronic publication date
    display
    2021 Dec 6
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34871104
    immutable id
    pubmed:34871104@01873c88922075833d26c3072f4890f84651e629d26e48e52b13ec1897f7088d
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    4
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    335-344
    volume
    40
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34871104
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      d805c0acbd0c61a9d03c57e41cb6fb1c64a8ccb39783030c58d1cb9015ba7f90
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Feb 1
      precision
      day
      year
      2022
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34871104/
      title
      Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.

      Preserved source evidence · Not medical advice